These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
214 related articles for article (PubMed ID: 32183018)
21. Community consensus for Heparan sulfate as a biomarker to support accelerated approval in Neuronopathic Mucopolysaccharidoses. Muenzer J; Ho C; Lau H; Dant M; Fuller M; Boulos N; Dickson P; Ellinwood NM; Jones SA; Zanelli E; O'Neill C Mol Genet Metab; 2024 Jul; 142(4):108535. PubMed ID: 39018614 [TBL] [Abstract][Full Text] [Related]
22. Quantification of glycosaminoglycans in urine by isotope-dilution liquid chromatography-electrospray ionization tandem mass spectrometry. Zhang H; Young SP; Millington DS Curr Protoc Hum Genet; 2013; Chapter 17():Unit 17.12. PubMed ID: 23315926 [TBL] [Abstract][Full Text] [Related]
23. An At-Risk Population Screening Program for Mucopolysaccharidoses by Measuring Urinary Glycosaminoglycans in Taiwan. Lin HY; Lee CL; Lo YT; Tu RY; Chang YH; Chang CY; Chiu PC; Chang TM; Tsai WH; Niu DM; Chuang CK; Lin SP Diagnostics (Basel); 2019 Oct; 9(4):. PubMed ID: 31590383 [TBL] [Abstract][Full Text] [Related]
26. Assessment of bone dysplasia by micro-CT and glycosaminoglycan levels in mouse models for mucopolysaccharidosis type I, IIIA, IVA, and VII. Rowan DJ; Tomatsu S; Grubb JH; Montaño AM; Sly WS J Inherit Metab Dis; 2013 Mar; 36(2):235-46. PubMed ID: 22971960 [TBL] [Abstract][Full Text] [Related]
27. Quantification of globotriaosylsphingosine in plasma and urine of fabry patients by stable isotope ultraperformance liquid chromatography-tandem mass spectrometry. Gold H; Mirzaian M; Dekker N; Joao Ferraz M; Lugtenburg J; Codée JD; van der Marel GA; Overkleeft HS; Linthorst GE; Groener JE; Aerts JM; Poorthuis BJ Clin Chem; 2013 Mar; 59(3):547-56. PubMed ID: 23237761 [TBL] [Abstract][Full Text] [Related]
28. Efficient analysis of urinary glycosaminoglycans by LC-MS/MS in mucopolysaccharidoses type I, II and VI. Auray-Blais C; Bhérer P; Gagnon R; Young SP; Zhang HH; An Y; Clarke JT; Millington DS Mol Genet Metab; 2011 Jan; 102(1):49-56. PubMed ID: 20934363 [TBL] [Abstract][Full Text] [Related]
29. Separation of sulfated urinary glycosaminoglycans by high-resolution electrophoresis for isotyping of mucopolysaccharidoses in Malaysia. Nor A; Zabedah MY; Norsiah MD; Ngu LH; Suhaila AR Malays J Pathol; 2010 Jun; 32(1):35-42. PubMed ID: 20614724 [TBL] [Abstract][Full Text] [Related]
30. Reduction of elevated plasma globotriaosylsphingosine in patients with classic Fabry disease following enzyme replacement therapy. van Breemen MJ; Rombach SM; Dekker N; Poorthuis BJ; Linthorst GE; Zwinderman AH; Breunig F; Wanner C; Aerts JM; Hollak CE Biochim Biophys Acta; 2011 Jan; 1812(1):70-6. PubMed ID: 20851180 [TBL] [Abstract][Full Text] [Related]
31. Two-dimensional NMR spectroscopy of urinary glycosaminoglycans from patients with different mucopolysaccharidoses. Hochuli M; Wüthrich K; Steinmann B NMR Biomed; 2003 Jun; 16(4):224-36. PubMed ID: 14558120 [TBL] [Abstract][Full Text] [Related]
32. Mental retardation in mucopolysaccharidoses correlates with high molecular weight urinary heparan sulphate derived glucosamine. Coppa GV; Gabrielli O; Zampini L; Maccari F; Mantovani V; Galeazzi T; Santoro L; Padella L; Marchesiello RL; Galeotti F; Volpi N Metab Brain Dis; 2015 Dec; 30(6):1343-8. PubMed ID: 26016623 [TBL] [Abstract][Full Text] [Related]
34. The levels of urinary glycosaminoglycans of patients with attenuated and severe type of mucopolysaccharidosis II determined by liquid chromatography-tandem mass spectrometry. Mashima R; Sakai E; Tanaka M; Kosuga M; Okuyama T Mol Genet Metab Rep; 2016 Jun; 7():87-91. PubMed ID: 27331006 [TBL] [Abstract][Full Text] [Related]